Introduction
A common feature in the topical attention to nanotechnology is that ethical issues are considered alongside research and development strategies. The field has drawn ethical discourse from a wide range of academic disciplines but scientists working in nanotechnology are also encouraged to engage with issues beyond the technical dimensions of their work. This is particularly the case in 'nanomedicine', which for the purpose of this paper is defined as the application of nanotechnology to achieve breakthroughs in healthcare [1] . A perceived possibility that society may view the introduction of this technology with concern and scepticism is reflected in a number of policy documents asking scientists to discuss social and ethical issues of their work. For example, a European Science Foundation
Report on Nanomedicine recommends "engagement of the scientific community in regular dialogue with the general public" [2] and the European Technology
Platform on Nanomedicine recommends a number of measures including "Media training of scientists, to teach them to work with the public and especially with journalists" [1] .
Evidently, those who work in nanotechnology can expect to be challenged as to their 'ethics awareness'. As a nanotechnological innovation being introduced at a time of great debate around biotechnology and biomedical ethics, nanomedicine has had its share of attention in the ethics literature.
Here, questions have been about health risks and benefits, privacy issues, the potential use of therapeutics for human enhancement [3] as well as social justice and access to health care [4] . In previous studies addressing how nanotechnology researchers perceive ethics, scientists have been included as one group alongside other professionals with a more indirect engagement in the field [5] [6] [7] .
However, there is limited understanding regarding what scientists 'on the ground' and specifically within the nanomedicine research field consider to be ethical issues in this context and how these scientists are positioning themselves to react to such issues in their practical work. This question has to be embedded in the wider conceptualization of the role of scientists as experts and authorities. In some countries, cultures and contexts the traditional role of scientists as authority figures has come under criticism [8] , and there is a prevalent challenge in integrating the consideration of scientific complexities and their governance especially in situations where scientific and ethical questions are entwined [9] .
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Semi-Structured Interview Design
Themes and questions for semi-structured interviews were designed to encompass the questions listed in [14] ). "Nanomedicine", "ethics", and "risks" are examples of categories created a priori. In order to categorize each extract of the interviews as representative of the different 'discourses' that structured the meaning attached to "risks", we created several subcategories of "risks" based on the data which were then classified according to how and in which context they were described by the interviewees, such as: "specific risk", "new risks", "environmental risks", "health risks", "risks related to nanoparticles". For example, the segment "nanorobots" as a "risk" was integrated in the category "health risks".
The same text segments were read and analyzed by 
Results
The results, presented in the following paragraphs, Some interviewees -exclusively more senior researchers -described the field more ambiguously.
On the one hand they considered the area new because it corresponds to an evolution of knowledge (implications, technique, paradigm) and in terms of working at the nanometer scale, while at the same time these respondents reflected that the area was not entirely "new" because some research under this label is not.
"The word nanomedicine as a term, just as tissue engineering, for example, and many others, is a bit in fashion. Almost everything came to be included in this concept. A few years ago it was not common to use the terminology nanomedicine, it wasn't in fashion, but already then there were scientists working in nanomedicine" (Interviewee 15)
Indeed, when asked whether they considered nanomedicine "a buzzword", a "show-off" term, more than half of the respondents agreed that it was often used in this way not only in media but also by scientists. Nevertheless, respondents felt that the current attention of funding agencies to nanotechnology is justified.
Concepts of risks and ethics
As presented in Figure 2, In resolving ethical issues in their scientific workincluding actually resolving ethical issues that they have encountered as well as how they would hypothetically resolve these issues would they encounter them -the main resources for our respondents are discussions with other colleagues.
Many respondents indicated that they discuss, share doubts and opinions and try to clarify issues as far as possible with colleagues. These colleagues may be from the own research group, from the own institution or from other national and international institutions, and some of the interviewees also mention seeking the advice of colleagues they consider "opinion leaders" in specific areas:
"I look for the opinion of colleagues who face the same or similar problems in their own countries, who know or at least have an opinion, and I try to find out how they have acted" (Interviewee 10)
Of 
Discussion
By providing data from in-depth interviews with researchers engaged in the field of nanomedicine, this case-study report adds empirical information to the often speculative discussion around ethical issues on this topic. While it has been suggested that nanomedical ethics as a field has not received much attention [15] it certainly cannot be alleged that the topic has not been charted analytically (e.g. [3] [4] [5] [16] [17] [18] ). In addition to these mainly theoretical discussions of potential ethical issues, the general public perception has been mapped through public consultations (e. g. [19] who study and monitor the environmental materials that are created by the 'upstream' scientists [7] . The different attitudes to risk of these groups have been 
Future perspective
The developments of nanotechnology and engineering at the nanoscale as well as the application in health constitute an ongoing challenge for society. This is true today and will not change soon as the field is fast moving. While the current state of the structural ethical issues posed by nanomedicine may not be so different from other biomedical fields, this may change in the future.
National and European public investment in nanoscience and nanotechnology continues to increase for medical devices and nanotechnology based medicines. "From the lab to the clinic" becomes the slogan that will mark the next step to ensure that more and more medical products based on this technology will arrive on the market. The expected success of these diagnostics and therapeutics innovations will raise new concerns about safe product implementation, regulatory policies and economical governance and also possibly raise socio-ethical issues that need to be discussed publicly. We hold that it is of utmost importance that scientists working in the field become more engaged in ethics in order to be prepared to identify and assess new or additional issues (and possible responses to these issues).
Providing an "expert assessment" of some presumed trends and expectations on how the field will evolve, will have an influence on the debates of other audiences (academic, regulatory, and industry stakeholders). The contribution of scientists analyzing and evaluating ethical issues can help to minimize the gap between "fantasy" and "reality" and will increase the awareness of the advantages of nanomedicine to improve human health and its risks.
Obviously this does not mean that scientists should 
